Phoenix Test For Multiple System Atrophy

CND Life Sciences is a pioneering company dedicated to revolutionizing the diagnosis of synucleinopathies, including Parkinson's disease, through its innovative Syn-One Test. This first commercially available skin-based test offers clinicians a reliable tool to detect abnormal alpha-synuclein in skin biopsies, boasting a high sensitivity and specificity of 95%.

With a commitment to advancing neurodiagnostics, CND Life Sciences emphasizes a patient-focused mission, providing valuable insights that empower both physicians and patients. Their CLIA-certified and CAP-accredited lab ensures accuracy and reliability, supporting critical clinical judgments in patient care.

Generated from the website